skip to content »

Center for Cell and Gene Therapy

Houston, Texas

Center for Cell and Gene Therapy
Center for Cell and Gene Therapy
not shown on screen

Sickle Cell Disease / Thalassemia

H14539; Allogeneic Stem Cell Transplantation from HLA Matched Unrelated Donors for Patients with Severe Homozygous B 0/+ Thalassemia or Severe Variants of B 0/+ Thalassemia (THALLO): This study uses a monoclonal antibody and high dose chemotherapy in combination with allogeneic (unrelated donor) stem cell transplantation to treat patients with Thalassemia.

H16447; Allogeneic Bone Marrow Transplantation from HLA Identical Related Donors for Patients with Hemoglobinopathies: Hemoglobin SS, Hemoglobin SC, or Hemoglobin SB0/+ Thallassemia (SCALLOP): This study uses a monoclonal antibody and high dose chemotherapy in combination with allogeneic (related donor) stem cell transplantation to treat patients with Thallassemia.

H30387; Unrelated Donor Reduced Intensity Bone Marrow Transplant for Children with Severe Sickle Cell Disease (BMT CTN 0601): This study uses reduced intensity chemotherapy followed by an allogeneic stem cell transplant to treat patients with sickle cell disease.

E-mail this page to a friend